One company I've been keeping track of is appearing to be making major headway in cellular immunotherapy along with several other interesting health related therapies/treatments.
At 9:30AM EST Monday, you'll receive the complete report.
Before the opening bell arrives, here's a quick taste of what's to come.
New Nasdaq Biotech Idea - 3 Potential Breakout Catalysts
#1. Heading into the weekend, this profile was displaying several oversold leaning technicals and was trading around its 52-week lows.
Could a healthy reversal be right around the corner after a recent downtrend?
#2. The company recently released an end of 2021 business update highlighting its major accomplishments from last year. They believe they are in a great position to carry through with their growth strategy in 2022 and beyond.
As these highlights continue to make the rounds, it could draw serious attention to this under-the-radar company.
#3. This is another low float idea which means that volatility can arise on a daily basis. According to Yahoo Finance, this profile has fewer than 35Mn shares in its float.
Could these 3 potential catalysts provide a breakout spark near term for this Nasdaq biotech idea?
Since you've got a minute, do this:
